Acta Scientific Ophthalmology (ISSN: 2582-3191)

Review Article Volume 7 Issue 8

Understanding Retinoblastoma: A Comprehensive Overview

Manish Kumar Sah1*, Brinda KC2, Usha Rai2 and Mohammad Atiullah2

1Assistant Professor, Optometry, SSAHS, Sharda University, Greater Noida, U.P., India
2B.Optom Student, Optometry, SSAHS, Sharda University, Greater Noida, U.P., India

*Corresponding Author: Manish Kumar Sah, Assistant Professor, Optometry, SSAHS, Sharda University, Greater Noida, U.P., India.

Received: July 11, 2024; Published: July 31, 2024

Abstract

Retinoblastoma is a rare but serious pediatric eye cancer characterized by tumors that originate in the retina due to genetic mutations, predominantly affecting children under five years old. Early detection through routine eye exams and advanced imaging techniques such as ultrasound and MRI is critical for timely diagnosis and treatment. Genetic testing plays a pivotal role in identifying mutations in the RB1 gene, guiding both prognosis and therapeutic decisions. Treatment strategies vary based on tumor size, location, and genetic factors, encompassing chemotherapy, localized therapies (laser/cryotherapy), radiation, and occasionally enucleation. Recent advancements include targeted therapies and intra-arterial chemotherapy, aimed at improving efficacy while minimizing systemic toxicity. Multidisciplinary care involving pediatric oncologists, ophthalmologists, geneticists, and supportive care providers ensures comprehensive management addressing medical, psychological, and social needs. Despite therapeutic advancements, challenges such as preserving vision and managing long-term sequelae remain, emphasizing the need for ongoing research and collaborative efforts. Keywords: retinoblastoma, pediatric cancer, RB1 gene, early detection, treatment strategies, multidisciplinary care, genetic testing, advanced imaging.

Keywords: Retinoblastoma; Pediatric Cancer; Psychosocial Support; Multidisciplinary Care

References

  1. Alkatan Hind Manaa., et al. "Demographics of Pediatric Orbital Lesions: A Tertiary Eye Center Experience in Saudi Arabia”. Journal of Epidemiology and Global Health 1 (2019): 3-10.
  2. Mattosinho Clarissa Campolina De Sá., et al. "Time to Diagnosis of Retinoblastoma in Latin America: A Systematic Review”. Pediatric Hematology and Oncology 2 (2019): 55-72.
  3. Dimaras Helen., et al. "Retinoblastoma (Primer)”. Nature Reviews: Disease Primers 1 (2015).
  4. Kaewkhaw Rossukon and Duangnate Rojanaporn. "Retinoblastoma: Etiology, Modeling, and Treatment”. Cancers 8 (2020): 2304.
  5. Bishop JO and MADSON EC. "Retinoblastoma Review of the Current Status”. (1975).
  6. Nag Adwaita and Vikas Khetan. "Retinoblastoma–a Comprehensive Review, Update and Recent Advances”. Indian Journal of Ophthalmology 6 (2024): 778-788.
  7. Dimaras Helen., et al. "Retinoblastoma”. Nature Reviews Disease Primers 1 (2015): 1-23.
  8. Dimaras Helen., et al. "Retinoblastoma”. The Lancet 9824 (2012): 1436-1446.
  9. Munier, Francis L., et al. "Conservative Management of Retinoblastoma: Challenging Orthodoxy without Compromising the State of Metastatic Grace”.Alive, with Good Vision and No Comorbidity”. Progress in Retinal and Eye Research 73 (2019): 100764.
  10. Nichols, Kim E., et al. "Recent Advances in Retinoblastoma Genetic Research”. Current opinion in ophthalmology 5 (2009): 351-55.
  11. Ortiz Michael V and Ira J Dunkel. "Retinoblastoma”. Journal of child neurology 2 (2016): 227-36.
  12. Shields Jerry A and Jerry A Shields. Intraocular Tumors. W.B. Saunders Company, 1992.
  13. Ishaq H and Patel BC. "Retinoblastoma”. StatPearls Publishing August 8, 2023. Web. 09/7/24.
  14. Abramson David H., et al. "Presenting Signs of Retinoblastoma”. The Journal of Pediatrics 3 (1998): 505-08.
  15. Murphree A Linn. "Intraocular Retinoblastoma: The Case for a New Group Classification”. Ophthalmology Clinics of North America 1 (2005): 41-viii.
  16. Chantada Guillermo., et al. "A Proposal for an International Retinoblastoma Staging System”. Pediatric Blood and Cancer 6 (2006): 801-805.
  17. Moulin Alexandre P., et al. "Ultrasound Biomicroscopy Evaluation of Anterior Extension in Retinoblastoma: A Clinicopathological Study”. British Journal of Ophthalmology 3 (2012): 337-340.
  18. Shields J and C Shields. "Retinoblastoma: Diagnostic Approaches”. In Atlas of Intraocular Tumors, Lippinoctt, Wolters Kluwer, Philadelphia, 3rd ed edition (2016).
  19. Chawla Bhavna., et al. "Correlation between Clinical Features, Magnetic Resonance Imaging, and Histopathologic Findings in Retinoblastoma: A Prospective Study”. Ophthalmology 4 (2012): 850-856.
  20. Hungerford JL., et al. "External Beam Radiotherapy for Retinoblastoma: I. Whole Eye Technique”. British Journal of Ophthalmology 2 (1995): 109-111.
  21. Pradhan Deepak G., et al. "Radiation Therapy for Retinoblastoma: A Retrospective Review of 120 Patients”. International Journal of Radiation Oncology* Biology* Physics 1 (1997): 3-13.
  22. Ancona-Lezama David., et al. "Modern Treatment of Retinoblastoma: A 2020 Review”. Indian Journal of Ophthalmology 11 (2020): 2356-2365.
  23. Shields Carol L., et al. "Plaque Radiotherapy in the Management of Retinoblastoma: Use as a Primary and Secondary Treatment”. Ophthalmology 2 (1993): 216-224.
  24. Pandey Achyut N. "Retinoblastoma: An Overview”. Saudi Journal of Ophthalmology 4 (2014): 310-315.
  25. Shields Carol L., et al. "Plaque Radiotherapy for Retinoblastoma: Long-Term Tumor Control and Treatment Complications in 208 Tumors”. Ophthalmology 11 (2001): 2116-2121.
  26. Abramson David H and Amy C Schefler. "Transpupillary Thermotherapy as Initial Treatment for Small Intraocular Retinoblastoma: Technique and Predictors of Success”. Ophthalmology 5 (2004): 984-991.
  27. Shields Carol L., et al. "Thermotherapy for Retinoblastoma”. Archives of Ophthalmology 7 (1999): 885-893.
  28. Chawla Bhavna. "Retinoblastoma: Diagnosis, Classification and Management”. Intraocular Tumors (2020): 1-18.
  29. Almater Abdullah., et al. "Retinoblastoma: Update on Current Management”. Retinoblastoma—Past, Present and Future (2019).
  30. Ancona-Lezama David., et al. "Ophthalmic Vascular Events after Intra‐Arterial Chemotherapy for Retinoblastoma: Real-World Comparison between Primary and Secondary Treatments”. Retina 12 (2019): 2264-2272.
  31. Gobin Y Pierre., et al. "Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma”. (2012).
  32. Dalvin Lauren A., et al. "Ophthalmic Vascular Events after Primary Unilateral Intra-Arterial Chemotherapy for Retinoblastoma in Early and Recent Eras”. Ophthalmology 11 (2018): 1803-1811.
  33. Manjandavida Fairooz P., et al. "Intra-Arterial Chemotherapy in Retinoblastoma–a Paradigm Change”. Indian Journal of Ophthalmology 6 (2019): 740-754.
  34. Shields Carol L and Jerry A Shields. "Retinoblastoma Management: Advances in Enucleation, Intravenous Chemoreduction, and Intra-Arterial Chemotherapy”. Current Opinion in Ophthalmology 3 (2010): 203-212.
  35. Shields Carol L., et al. "Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds: Preliminary Results”. JAMA Ophthalmology 3 (2014): 319-325.
  36. Francis Jasmine H., et al. "Risk of Extraocular Extension in Eyes with Retinoblastoma Receiving Intravitreous Chemotherapy”. JAMA Ophthalmology 12 (2017): 1426-1429.
  37. De Potter Patrick. "Current Treatment of Retinoblastoma”. Current Opinion in Ophthalmology 5 (2002): 331-336.
  38. Shields Jerry A., et al. "Decreasing Frequency of Enucleation in Patients with Retinoblastoma”. American Journal of Ophthalmology 2 (1989): 185-188.
  39. Chintagumpala Murali., et al. "Retinoblastoma: Review of Current Management”. The Oncologist 10 (2007): 1237-1246.
  40. Honavar Santosh G and Raksha Rao. "Enucleation and Exenteration”. Surgical Ophthalmic Oncology: A Collaborative Open Access Reference (2019): 131-39.

Citation

Citation: Manish Kumar Sah., et al. “Understanding Retinoblastoma: A Comprehensive Overview". Acta Scientific Ophthalmology 7.8 (2024): 41-49.

Copyright

Copyright: © 2024 Manish Kumar Sah., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is August 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US